Articles tagged with Chronic Obstructive Pulmonary Disease
A new study found that Aboriginal Australians have low forced vital capacity due to environmental and socioeconomic factors. This discovery challenges the previous notion of chronic obstructive pulmonary disease (COPD) being more common among Aboriginal Australians.
A healthy diet rich in whole grains and polyunsaturated fats is associated with a lower risk of chronic lung disease, according to a study published in The BMJ. The Alternate Healthy Eating Index 2010 was found to be linked to a one-third lower risk of newly diagnosed COPD.
A small group of COPD patients who drank beetroot juice before exercise were able to extend their exercise time and had reduced blood pressures compared to those who received a placebo. The study found beneficial effects of dietary nitrite supplementation on exercise performance and blood pressure in patients with COPD.
Only 2.2% of American physicians have DEA waivers for prescribing buprenorphine-naloxone, a treatment for opioid use disorder, with most practicing in urban counties. This scarcity limits treatment options in rural areas, leaving over 30 million persons without access to this life-saving medication.
A new study from Queen Mary University of London found that vitamin D supplements can significantly reduce the risk of COPD flare-ups in patients with a vitamin D deficiency. The trial, which included 240 patients, showed a 40% reduction in flare-ups among those who received vitamin D supplements.
Research found that people with asthma had a 27% higher incidence of Crohn's disease, while those with COPD had a 55% higher incidence compared to the general population. The study highlights the importance of early detection and treatment of bowel diseases in airway patients.
A study published in CHEST found that patients with COPD who received oral nutrition supplements had shorter hospital stays (21.5% reduction), lower total hospital costs ($1,570), and a 13.1% reduction in 30-day readmission rates. This suggests that nutrition treatment can have positive health outcomes for older adults with COPD.
Using community pharmacies to identify undiagnosed chronic obstructive pulmonary disease (COPD) cases at an early stage could save the NHS £264 million annually. The service has already been successful in screening over 238 people, identifying those at higher risk of COPD and providing lifestyle advice.
Asthma and chronic obstructive pulmonary disease (COPD) share similar symptoms, but the conditions have different causes and require unique treatment strategies. Accurate diagnosis is crucial to provide effective management for patients with overlapping characteristics of asthma and COPD.
A new University of Michigan analysis shows that penalties for chronic lung disease will disproportionately affect hospitals caring for poor and minority patients. The findings highlight the need for targeted interventions to address socioeconomic factors contributing to readmissions.
Patients using medication for asthma/COPD, high blood pressure, or oral contraceptives often purchase cigarettes while filling prescriptions. Study data reveals a significant co-purchase rate of cigarettes with these medications, highlighting the need to prevent cigarette purchasing by individuals at greatest risk.
A study published in JAMA Internal Medicine estimates that there are 14 million smoking-attributable major medical conditions in the US. The largest cause of these illnesses is chronic obstructive pulmonary disease (COPD), with an estimated 7.5 million cases attributable to smoking.
A new study by University at Buffalo confirms that COPD patients breathe easier and report improved health status when using the Lung Flute, a hand-held respiratory device. The six-month study shows significant improvements in symptoms and quality of life.
Researchers at Duke University Medical Center found that coaching patients with COPD to manage stress and practice relaxation can improve their physical symptoms, quality of life, and reduce depression and anxiety.
A study found that combination therapy with long-acting beta-agonists (LABAs) and inhaled corticosteroids (ICSs) is associated with a lower risk of death or COPD hospitalization among older adults with COPD, particularly those with asthma. The therapy also showed promise for patients without asthma.
A study published in Telemedicine and e-Health found that telemedicine can lead to fewer and shorter hospital stays, as well as fewer emergency room visits and even fewer deaths. The integration of telemedicine into healthcare adds great value in managing chronic disease.
A new observational study investigates the prevalence of paradoxical bronchoconstriction after using β2 agonists in smokers and ex-smokers with Chronic Obstructive Pulmonary Disease (COPD). The study reveals that African-American patients are twice as likely to experience a paradoxical response, leading to worse respiratory outcomes.
A randomized trial of 101 patients with chronic obstructive pulmonary disease found that benralizumab had no effect on acute exacerbation rates. However, subgroup analyses indicate the need for further investigation into the use of benralizumab in patients with COPD and eosinophilia.
Patients living with COPD want to discuss their palliative care needs with healthcare professionals, but feel uncomfortable bringing it up due to fear of burdening others. Healthcare professionals should not be afraid to initiate conversations about palliative care, as patients understand the seriousness of their condition.
A nationwide analysis of over 8,000 patients with COPD found that modifiable factors such as prescription adherence and follow-up care can reduce early readmissions. The study suggests that strategies to reduce hospital readmissions extend beyond quality of COPD-specific care.
A team of researchers will evaluate whether providing patients with COPD who experience rapid symptom deterioration with a care bundle improves hospital care and reduces readmission. The study aims to shape future health services to deliver better care for patients with chronic obstructive pulmonary disease (COPD) nationwide.
A study by The Miriam Hospital found that women with Chronic Obstructive Pulmonary Disease (COPD) who are also depressed have difficulty sticking to a pulmonary rehabilitation program. Lower depressed mood independently predicted finishing PR for women, but not men.
Research finds that excess belly fat, low physical activity, and underweight status increase COPD risk. People with larger waist circumference have a 72% higher chance of developing COPD.
Researchers developed a new method to predict disease progression by analyzing Denmark's entire population health records. The approach revealed surprising correlations between diseases, such as gout and cardiovascular disease, and showed that certain diagnoses are often followed by others in a causal sequence.
Researchers found that providing in-hospital counseling and post-care support can lead to significant health system savings while increasing the number of quitters. The Ottawa Model for Smoking Cessation (OMSC) was shown to be a cost-effective intervention, generating benefits in terms of reduced hospital readmissions and deaths.
A new study found that eating fish, fruit, and dairy products can improve lung function in patients with chronic obstructive pulmonary disease (COPD). The study analyzed data from over 2,167 participants and showed that those who consumed these foods had better lung function, less emphysema, and improved quality of life.
A new study found that an internet-mediated exercise program supported by online resources improved health-related quality of life and daily step count in COPD patients. The pedometer-based walking program led to a significant improvement in symptoms and impacts, with participants taking 779 more steps per day at 4 months.
A new study from Johns Hopkins University found that warmer indoor temperatures are linked to increased COPD symptoms, rescue medication use, and decreased lung function in patients. The research also suggests that even short periods of outdoor exposure to high temperatures can exacerbate the condition.
A large multicenter clinical trial led by Dr. Gerard J. Criner found that statin drugs do not reduce the number and severity of flare-ups from chronic obstructive pulmonary disease (COPD). The study tested the hypothesis that statins may be beneficial in persons with COPD due to their anti-inflammatory effect.
A study found that COPD patients have a significantly higher risk of heart failure compared to the general population, with African-American patients facing the highest risk. The study also revealed disparities in treatment and outcomes for patients with both conditions.
Research reveals that benzodiazepines can significantly increase the risk of respiratory issues in older adults with chronic obstructive pulmonary disease (COPD). This risk is consistent even after accounting for the severity of the person's illness.
A study of 6,042 patients with COPD found that those who exercised 150 minutes or more per week had a 34% lower risk of readmission within 30 days. Regular physical activity was also associated with improved quality of life and reduced hospitalizations.
A 9-year study found that biogas and improved kitchen ventilation improved lung function and reduced chronic obstructive pulmonary disease (COPD) risk. Participants who adopted these interventions retained more lung function as they aged, suggesting a significant reduction in indoor air pollution's adverse consequences on health.
A study found that older adults with chronic obstructive pulmonary disease (COPD) are at a higher risk for developing mild cognitive impairment (MCI), particularly in skills other than memory. Patients with COPD for over five years had the greatest risk, highlighting the importance of COPD as a risk factor for MCI.
A new study found that Medicare Part D prescription coverage significantly reduced hospital admissions by 8% and annual Medicare expenditures for hospitalization by 7%, resulting in aggregate savings of $1.5 billion per year. This expansion led to a 90% increase in seniors with prescription coverage.
A new decision tool, Ottawa COPD Risk Scale, identifies patients with COPD who are at risk of serious complications or death. The scale provides a quantitative estimate of risk for adverse events in patients with COPD.
Regular walking can significantly reduce the risk of severe COPD attacks and hospitalization. Patients who maintain moderate exercise levels, such as walking at least 3-6 km per day, are less likely to experience severe symptoms.
A recent UK study found that doctors are missing opportunities to diagnose chronic obstructive pulmonary disease (COPD) in up to 85% of cases. The study, published in The Lancet Respiratory Medicine, analyzed data from 38,859 patients and found that missed opportunities for diagnosis were most common in the years preceding diagnosis. T...
A 20-year retrospective study found that 85% of patients with chronic obstructive pulmonary disease (COPD) were overlooked by doctors, highlighting the need for improved early diagnosis and treatment. The study estimates that around 2.2 million people in the UK remain undiagnosed for COPD.
Researchers developed a new antibody that reverses muscle wasting in cancer, COPD, and other diseases by blocking a receptor that puts brakes on muscle development. The compound, BYM338, boosted muscle mass 25-50% and increased strength in animal models, with clinical trials underway.
A new UK review examines gender differences in COPD prevalence, pathophysiology, and clinical presentation. The study finds that women are increasingly affected by COPD due to changing smoking trends and environmental risk factors.
A study by the American College of Chest Physicians found that yoga training improved lung function, breathing, and quality of life in patients with chronic obstructive pulmonary disease (COPD). The 12-week program involved physical postures, breathing techniques, and meditation.
A new study from Brigham and Women's Hospital reveals four novel genetic variants associated with how people living with chronic obstructive pulmonary disease (COPD) respond to inhaled bronchodilators. The findings may reveal genetic pathways associated with the pathogenesis of COPD and identify novel treatment methods.
A genome-wide meta-analysis of COPD patients has identified novel gene variants associated with bronchodilator responsiveness. The study used data from over 6,000 patients and found that genetic determinants likely influence response to inhaled medication.
A new class of drug RPL554 has been developed to treat obstructive airway diseases like asthma and COPD. It works by both reversing the narrowing of the airways and reducing inflammation, producing a 17% increase in respiratory function.
A large international study has found that the drug tiotropium can be delivered safely and effectively to people with COPD using either a mist or traditional dry powder inhaler. The study showed no significant difference in the incidence of major cardiovascular events or risk of death between the two groups.
A new publication by the European Respiratory Society reveals that lung conditions account for 12.5% of EU deaths, with annual costs totaling at least 390 billion Euros. The White Book estimates direct and indirect costs due to lung diseases are around 400 billion Euros annually.
Researchers identified protein biomarkers that predict ovarian cancer recurrence and chronic obstructive pulmonary disease (COPD) development. The findings suggest a potential for using protein analysis to predict patient outcomes and guide treatment decisions in both diseases.
Researchers at WashU Medicine have identified a new therapeutic target for COPD by linking acute viral infections to chronic obstructive pulmonary disease. Viral infection triggers the production of IL-33, a signaling molecule that activates immune cells to produce excess mucus in the lungs.
Researchers found increased expression of interleukin-33 (IL-33) in human airways, linked to mucus production and other genes implicated in COPD. A mouse model also showed IL-33-producing epithelial progenitor cells induced by viral infection, suggesting potential therapeutic strategies.
A new study finds that continuous positive airway pressure (CPAP) therapy significantly reduces the risk of death in patients with chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA). The study, published in the Journal of Clinical Sleep Medicine, analyzed data from 3,396 patients who used CPAP for at least t...
Researchers have discovered that two receptors of leukotriene B4 play opposing roles in inflammation, with BLT1 promoting and BLT2 weakening inflammation during an allergic reaction. This finding suggests new approaches to developing anti-asthma and anti-COPD drugs.
Researchers found that COPD increases the risk of developing cerebral microbleeds in deep or infratentorial brain regions. The study also showed that COPD is associated with both large and small vessel disease, indicating a potential impact on overall vascular health.
A study of 61,650 participants found that elevated levels of C-reactive protein, fibrinogen, and leukocyte count are associated with an increased risk of COPD exacerbations. The risk is even higher in those with milder COPD and no previous exacerbations.
A study of 80 patients found that 42.5% had no obstruction, 23% had reversible obstruction, and only 35% had non-reversible obstruction, suggesting widespread misdiagnosis of COPD. The study highlights the importance of spirometry in confirming diagnosis and reducing unnecessary medical expenses.
A new study published in JAMA Network found that a 5-day glucocorticoid treatment course was non-inferior to a 14-day course in reducing re-exacerbation of chronic obstructive pulmonary disease (COPD) during 6 months of follow-up. The shorter-course regimen also resulted in significantly reduced glucocorticoid exposure.
A study of nearly 9,000 patients found that African-Americans are less likely than whites to have had a prior diagnosis of chronic obstructive pulmonary disease (COPD), regardless of their current disease severity. In contrast, women are more likely than men to have been diagnosed with COPD, even in the absence of airflow obstruction.
A new study suggests that physical activity levels can predict hospitalizations in COPD patients. The study found that those who were able to walk less than 350 meters during the six-minute walk distance and had lower vector magnitude unit scores were significantly more likely to be hospitalized. These findings underscore the importanc...
A study found that patients with COPD experience chronic pain comparable to those with osteoarthritis and rheumatoid arthritis, with higher use of opioids. The researchers also noted a significant impact on quality of life and healthcare costs.
Researchers at the University of Pittsburgh found a strong association between depressive symptoms and levels of interleukin-6, an inflammatory biomarker, in COPD patients. The study suggests that systemic inflammation may play a role in depression associated with COPD.